Monti E, Prosperi E, Supino R, Bottiroli G
Istituto di Farmacologia, Università di Milano, Italy.
Anticancer Res. 1995 Jan-Feb;15(1):193-7.
The role of free radicals in the genesis of adriamycin (ADR)-induced delayed cardiotoxicity and the cardioprotective effects of the spin trap N-tert-butyl-alpha-phenylnitrone (PBN) were investigated in an in vivo rat model. As ADR and free radicals are no longer present in the myocardium by the time the delayed effects of the drug become apparent, ADR has been proposed to act by causing early radical-dependent DNA lesions, resulting in impaired synthesis of critical target proteins. DNA lesions were detected 10 days after ADR treatment (3X3 mg/kg i.v.) and were still present at the time of onset of the delayed cardiomyopathy. PBN, administered by a slow-release osmotic pump to maintain constant plasma levels throughout the time of persistence of ADR in the myocardium (approximately 2 weeks), prevented the development of DNA lesions, as well as the late contractile and electrical impairment induced by the anthracycline, thus supporting the hypothesis that free radicals play a causal role in both phenomena.
在大鼠体内模型中研究了自由基在阿霉素(ADR)诱导的迟发性心脏毒性发生中的作用以及自旋捕捉剂N-叔丁基-α-苯基硝酮(PBN)的心脏保护作用。当药物的延迟效应变得明显时,ADR和自由基已不再存在于心肌中,因此有人提出ADR通过引起早期依赖自由基的DNA损伤起作用,导致关键靶蛋白合成受损。在ADR治疗(3×3mg/kg静脉注射)10天后检测到DNA损伤,并且在迟发性心肌病发作时仍然存在。通过缓释渗透泵给药PBN,以在ADR在心肌中持续存在的整个时间(约2周)内维持恒定的血浆水平,可预防DNA损伤的发生以及蒽环类药物引起的晚期收缩和电功能损害,从而支持自由基在这两种现象中起因果作用的假说。